SYRE - Company ID 0001636282
As of 2026-11-06, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $8.84 B, making it the #998 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $8.84 B |
| 2026-11-05 | $8.29 B |
| 2026-11-04 | $8.60 B |
| 2026-11-03 | $8.62 B |
| 2026-11-02 | $8.24 B |
| 2026-11-01 | $8.39 B |
| 2026-10-31 | $8.39 B |
| 2026-10-30 | $8.38 B |
| 2026-10-29 | $8.60 B |
| 2026-10-28 | $8.66 B |
| 2026-10-27 | $8.60 B |
| 2026-10-26 | $8.07 B |
As of 2026-11-06, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $8.84 B, making it the #998 most valuable US-listed company.
Spyre Therapeutics, Inc. is the #998 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $7.84 B |
| 2026-10-24 | $7.84 B |
| 2026-10-23 | $7.84 B |
| 2026-10-22 | $8.02 B |
| 2026-10-21 | $8.13 B |
| 2026-10-20 | $8.00 B |
| 2026-10-19 | $7.36 B |
| 2026-10-18 | $6.94 B |
| 2026-10-17 | $6.94 B |
| 2026-10-16 | $6.94 B |
| 2026-10-15 | $6.96 B |
| 2026-10-14 | $6.83 B |
| 2026-10-13 | $7.15 B |
| 2026-10-12 | $7.46 B |
| 2026-10-11 | $7.44 B |
| 2026-10-10 | $7.44 B |
| 2026-10-09 | $7.44 B |
| 2026-10-08 | $6.94 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.